3Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response crite ria for myelodysplastic syndromes [J]. Blood, 2000, 96 (12) :3671 - 3674.
4Greenberg P, Cox C, LeBeau MM, et al. International sco- ring system for evaluating prognosis in myelodysplastie syndromes[J]. Blood, 1997,89 (6) : 2079 - 2088.
3Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000; 96( 12):3671--3674.
4Ulrich G, Norbert G, Corinna S, et al. Validation of the WHO proposal for a new classifications of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk a Res 2000;25(12) : 983---993.
5Tsuda H, Yamasaki H. Type Ⅰ and type Ⅱ T-cells profiles in aplastic anemia and refractory anemia. Am J Hematol 2000;64 (4) : 271--274.
6Ohyashiki K, Ohyashiki JH, Iwabuchi A, et al. Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes. Leuk Lymphoma 1996 ;23 ( 5-6 ) : 409--415.
7Haase D, Fonatsch C, Freund M, et al. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 1995 ;70(4) : 171--187.
